SALTO TALARIS全踝关节置换至少10年随访:144踝的生存率与影像学及临床结果
多术者单中心回顾性研究纳入2009至2013年接受SALTO TALARIS全踝关节置换的164踝(155例),平均随访12年。10年无任何踝关节手术生存率94.1%,翻修至少一个金属组件生存率96.2%,转为融合生存率99%。末次随访AOFAS中位98分,43%踝被视为「遗忘」关节。
要点
- 10年无任何踝关节手术生存率为94.1%(95%CI 90.5%–97.9%)。
- 10年翻修至少一个金属组件生存率为96.2%(95%CI 93.4%–99.2%)。
- 末次随访AOFAS中位98分,43%踝为「遗忘」关节。
核心结论
- SALTO TALARIS全踝关节置换假体可靠,再手术率低,长期生存率优异。
- 结果为第三代固定承重全踝关节置换系统提供了长期参考生存数据。
研究设计与样本
- 多术者、单中心、回顾性研究,纳入2009至2013年手术的164踝(155例),平均年龄64.4岁,60%为女性,平均随访12年(范围10至15年)。
- 采用Kaplan-Meier法估算假体生存率,所有患者使用相同手术技术和一致的术前术后影像学评估。
主要发现
- 155例164踝初始纳入,17例(17踝)死亡,3例(3踝,1.8%)在10年前失访。
- 10年无任何涉及胫距关节手术的生存率为94.1%(95%CI 90.5%–97.9%)。
- 10年以翻修至少一个金属组件为终点的假体生存率为96.2%(95%CI 93.4%–99.2%)。
- 10年以取出并转为关节融合为终点的假体生存率为99%(95%CI 98%–100%)。
- 末次随访平均背屈12°±5°,平均跖屈23°±7°,AOFAS评分中位98分,62踝(43%)被视为「遗忘」关节。
关键数值与推荐
- 10年无任何踝关节手术生存率94.1%(95%CI 90.5%–97.9%)。
- 10年翻修至少一个金属组件生存率96.2%(95%CI 93.4%–99.2%)。
- 10年取出并转为关节融合生存率99%(95%CI 98%–100%)。
- 末次随访平均背屈12°±5°,平均跖屈23°±7°,AOFAS评分中位98分。
临床怎么用
- 对于终末期胫距关节骨关节炎患者,SALTO TALARIS全踝关节置换可提供低再手术率和优异长期生存。
- 术后10年以上随访中,患者可维持一定活动度且AOFAS评分优良,部分患者可获得「遗忘」关节体验。
局限性
- 单中心回顾性设计可能限制结果外推。
- 17例死亡和3例失访可能对生存分析产生一定影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Total ankle arthroplasty (TAA) is increasingly performed worldwide for the treatment of end-stage tibiotalar osteoarthritis. There are limited data in the literature regarding the long-term survival of third-generation implants. The primary aim of this study was to characterize the long-term survival of the SALTO TALARIS TAA implant. METHODS: This was a multisurgeon, single-center, retrospective study of 164 consecutive ankles (155 patients) that underwent surgery between 2009 and 2013. The mean age at surgery was 64.4 years, and 60% of patients were women. The mean follow-up was 12 years (range, 10 to 15 years). Implant survival was estimated using the Kaplan-Meier method. Data collected included implant survival, clinical range of motion, American Orthopaedic Foot & Ankle Society (AOFAS) score, and the number of patients with a "forgotten" joint. The same surgical technique and identical pre- and postoperative radiographic assessments were used for all patients. RESULTS: One hundred and fifty-five patients with 164 TAAs were initially included; 17 patients (17 TAAs) died, and 3 patients (3 TAAs, 1.8%) were lost to follow-up before 10 years. Survival free from any surgery involving the tibiotalar joint was 94.1% (95% confidence interval [CI]: 90.5% to 97.9%) at 10 years. Implant survival with the end point of revision of at least 1 metallic component was 96.2% (95% CI: 93.4% to 99.2%) at 10 years. Implant survival with the end point of removal and conversion to arthrodesis was 99% (95% CI: 98% to 100%) at 10 years. At the latest follow-up, the mean dorsiflexion (and standard deviation) was 12° ± 5°, the mean plantar flexion was 23° ± 7°, and the median AOFAS score was 98. Patients considered 62 (43%) of the ankles "forgotten" joints. CONCLUSIONS: The SALTO TALARIS TAA is a reliable implant with a low reoperation rate and excellent long-term survival. These findings provide long-term reference survival data for a third-generation fixed-bearing TAA system. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.
引用
- Sadoun M, Gaudot F, Bauer T, et al. SALTO TALARIS Total Ankle Arthroplasty at a Minimum of 10 Years of Follow-up: Survival and Radiographic and Clinical Outcomes in a Series of 144 Ankles. J Bone Joint Surg Am. 2026. PMID: 42301246. doi:10.2106/JBJS.25.01483
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。